| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |